Live feed
Filing
SC 13G
SC 13G0000921895-21-002878·BIOTECHNOLOGY VALUE FUND L P
Schedule 13G ownership disclosure
Relmada Therapeutics Inc
Security class unavailable · CUSIP: 75955J402
Event date: 2021-12-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-21-002878
- Form type
- SC 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Dec 20, 2021
- Reporting period
- Dec 09, 2021
- Description
- Schedule 13G beneficial ownership